EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Is SARS ‐ CoV ‐2 Infection ( COVID ‐19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS ‐ CoV ‐2 Infection in Wales

Samantha Rose Fisher, Robert Maddison‐Jarvis, Penelope Cresswell‐Jones, David Tucker, Llion Davies

Birth Defects Research · 2026-11 · 118 (11)

DOI: 10.1002/bdr2.70122 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objectives Explore the relationship between maternal SARS‐CoV‐2 infection and congenital anomalies in Wales. Study Design Mixed observational epidemiological cross‐sectional and cohort. Methods Congenital anomaly prevalence data were provided by the Congenital Anomaly Register and Information Service. Two comparisons were made using these data: firstly, congenital anomaly subgroup prevalence prior to and during the pandemic at population level, and in a cohort of women with laboratory‐confirmed maternal SARS‐CoV‐2 infection compared with the population trend. Results Prevalence of congenital anomalies in Wales was lower during the pandemic (mean 365 per 10,000 in 2020–22 vs. 454 per 10,000 in 2009–19) showing stable trends. However, the mean for abdominal wall defects increased from 9.8 per 10,000 births between 2009 and 2019 to 13.9 per 10,000 births in 2020–2022, largely attributed to an increase in omphalocele. A cohort of 486 confirmed maternal SARS‐CoV‐2 infections led to 181 births affected by congenital anomalies, and the trimester of infection did not impact the adjusted odds of this occurring. Circulatory anomalies were most frequently reported, consistent with pre‐pandemic population‐level data. Urinary and cardiac anomalies were more prevalent in this cohort group than at population level. Conclusions There was no clear evidence at population‐level of an association between congenital anomalies and maternal SARS‐CoV‐2 infection in Wales. However, a potential association with specific congenital anomalies cannot be excluded. Increased omphalocele is consistent with a Europe‐wide trend that pre‐dated COVID‐19. National surveillance registries should remain vigilant.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →